Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein
Publication
, Conference
Tomaka, F; Stieh, D; Barouch, D; Robb, M; Michael, N; Tomaras, G; Alter, G; McElrath, J; Lavreys, L; Nijs, S; Callewaert, K; Hendriks, J ...
Published in: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
July 1, 2018
Duke Scholars
Published In
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
EISSN
1758-2652
Publication Date
July 1, 2018
Volume
21
Start / End Page
2 / 3
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1199 Other Medical and Health Sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tomaka, F., Stieh, D., Barouch, D., Robb, M., Michael, N., Tomaras, G., … Schuitemaker, H. (2018). Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 21, pp. 2–3). JOHN WILEY & SONS LTD.
Tomaka, F., D. Stieh, D. Barouch, M. Robb, N. Michael, G. Tomaras, G. Alter, et al. “Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein.” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 21:2–3. JOHN WILEY & SONS LTD, 2018.
Tomaka F, Stieh D, Barouch D, Robb M, Michael N, Tomaras G, et al. Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2018. p. 2–3.
Tomaka, F., et al. “Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein.” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 21, JOHN WILEY & SONS LTD, 2018, pp. 2–3.
Tomaka F, Stieh D, Barouch D, Robb M, Michael N, Tomaras G, Alter G, McElrath J, Lavreys L, Nijs S, Callewaert K, Hendriks J, Euler Z, Pau M, Schuitemaker H. Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2018. p. 2–3.
Published In
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
EISSN
1758-2652
Publication Date
July 1, 2018
Volume
21
Start / End Page
2 / 3
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1199 Other Medical and Health Sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences